3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|Eppendorf epMotion 5070|
|A perfect match for all liquid handling applications, such as serial dilutions, reagent distribution PCR/qPCR and sequencing setup.|
|Our goal is to empower your genomics research. Our proprietary technology can translate into significant sequence cost reductions.|
|High quality Epitomics Rabbit Monoclonal Antibodies to EGFR, Akt, Her2, ATM, and More. Click here to learn more|